Literature DB >> 17018591

Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma.

Quintin Pan1, Li Wei Bao, Theodoros N Teknos, Sofia D Merajver.   

Abstract

Over 70% of patients with head and neck squamous cell carcinoma (HNSCC) present with locoregionally advanced stage III and IV disease. In spite of aggressive therapy, locoregional disease recurs in 60% and metastatic disease develops in 15% to 25% of patients causing a major decline in quality and length of life. Therefore, there is a need to identify and understand genes that are responsible for inducing an aggressive HNSCC phenotype. Evidence has shown that protein kinase C (PKC) epsilon is a transforming oncogene and may play a role in HNSCC progression. In this study, we determine the downstream signaling pathway mediated by PKC epsilon to promote an aggressive HNSCC phenotype. RNA interference knockdown of PKC epsilon in UMSCC11A and UMSCC36, two highly invasive and motile HNSCC cell lines with elevated endogenous PKC epsilon levels, resulted in cells that were significantly less invasive and motile than the small interfering RNA-scrambled control transfectants; 51 +/- 5% (P < 0.006) and 49 +/- 3% (P < 0.010) inhibition in invasion and 69 +/- 1% (P < 0.0005) and 66 +/- 3% (P < 0.0001) inhibition in motility, respectively. PKC epsilon-deficient UMSCC11A clones had reduced levels of active and serine-phosphorylated RhoA and RhoC. Moreover, constitutive active RhoA completely rescued the invasion and motility defect, whereas constitutive active RhoC completely rescued the invasion and partially rescued the motility defect of PKC epsilon-deficient UMSCC11A clones. These results indicate that RhoA and RhoC are downstream of PKC epsilon and critical for PKC epsilon-mediated cell invasion and motility. Our study shows, for the first time, that PKC epsilon is involved in a coordinated regulation of RhoA and RhoC activation, possibly through direct post-translational phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17018591      PMCID: PMC4383316          DOI: 10.1158/0008-5472.CAN-06-2646

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Protein kinase Calpha-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement.

Authors:  Michael Holinstat; Dolly Mehta; Tohru Kozasa; Richard D Minshall; Asrar B Malik
Journal:  J Biol Chem       Date:  2003-05-16       Impact factor: 5.157

2.  Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma.

Authors:  A P Jansen; E G Verwiebe; N E Dreckschmidt; D L Wheeler; T D Oberley; A K Verma
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

3.  Motility-related proteins as markers for head and neck squamous cell cancer.

Authors:  M T Abraham; M A Kuriakose; P G Sacks; H Yee; L Chiriboga; E L Bearer; M D Delacure
Journal:  Laryngoscope       Date:  2001-07       Impact factor: 3.325

4.  Rho GTPases are over-expressed in human tumors.

Authors:  G Fritz; I Just; B Kaina
Journal:  Int J Cancer       Date:  1999-05-31       Impact factor: 7.396

5.  Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells.

Authors:  Malvyne Rolli-Derkinderen; Vincent Sauzeau; Laurent Boyer; Emmanuel Lemichez; Céline Baron; Daniel Henrion; Gervaise Loirand; Pierre Pacaud
Journal:  Circ Res       Date:  2005-05-12       Impact factor: 17.367

6.  Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability.

Authors:  Celina G Kleer; Kenneth L van Golen; Yanhong Zhang; Zhi-Fen Wu; Mark A Rubin; Sofia D Merajver
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

7.  The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts.

Authors:  A M Cacace; S N Guadagno; R S Krauss; D Fabbro; I B Weinstein
Journal:  Oncogene       Date:  1993-08       Impact factor: 9.867

8.  Alterations in levels of different protein kinase C isotypes and their influence on behavior of squamous cell carcinoma of the oral cavity: epsilon PKC, a novel prognostic factor for relapse and survival.

Authors:  C Martínez-Gimeno; M T Díaz-Meco; I Domínguez; J Moscat
Journal:  Head Neck       Date:  1995 Nov-Dec       Impact factor: 3.147

Review 9.  Overview of combined modality therapies for head and neck cancer.

Authors:  I W Dimery; W K Hong
Journal:  J Natl Cancer Inst       Date:  1993-01-20       Impact factor: 13.506

10.  Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters.

Authors:  G Fritz; C Brachetti; F Bahlmann; M Schmidt; B Kaina
Journal:  Br J Cancer       Date:  2002-09-09       Impact factor: 7.640

View more
  40 in total

Review 1.  Molecular parameters of head and neck cancer metastasis.

Authors:  Sanjay L Bhave; Theodoras N Teknos; Quintin Pan
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

Review 2.  Target validation to biomarker development: focus on RNA interference.

Authors:  Riccardo Colombo; Jürgen Moll
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

3.  Preclinical development of a bifunctional cancer cell homing, PKCepsilon inhibitory peptide for the treatment of head and neck cancer.

Authors:  Liwei Bao; Michael A Gorin; Manchao Zhang; Alejandra C Ventura; William C Pomerantz; Sofia D Merajver; Theodoros N Teknos; Anna K Mapp; Quintin Pan
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

Review 4.  The substrates and binding partners of protein kinase Cepsilon.

Authors:  Philip M Newton; Robert O Messing
Journal:  Biochem J       Date:  2010-03-29       Impact factor: 3.857

Review 5.  Protein kinase C and cancer: what we know and what we do not.

Authors:  R Garg; L G Benedetti; M B Abera; H Wang; M Abba; M G Kazanietz
Journal:  Oncogene       Date:  2013-12-16       Impact factor: 9.867

Review 6.  Glycogen synthase kinase 3 beta: can it be a target for oral cancer.

Authors:  Rajakishore Mishra
Journal:  Mol Cancer       Date:  2010-06-11       Impact factor: 27.401

7.  Protein kinase Cvarepsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2).

Authors:  M H Aziz; B B Hafeez; J M Sand; D B Pierce; S W Aziz; N E Dreckschmidt; A K Verma
Journal:  Oncogene       Date:  2010-03-15       Impact factor: 9.867

Review 8.  PKC signaling in glioblastoma.

Authors:  Anália do Carmo; Joana Balça-Silva; Diana Matias; Maria Celeste Lopes
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

9.  MicroRNA Signatures of Colonic Polyps on Screening and Histology.

Authors:  Vassiliki L Tsikitis; Amiee Potter; Motomi Mori; Julie A Buckmeier; Christina R Preece; Christina A Harrington; Angela N Bartley; Achyut K Bhattacharyya; Stanley R Hamilton; M Peter Lance; Patricia A Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2016-09-22

10.  Protein kinase Cepsilon is important for migration of neuroblastoma cells.

Authors:  Helena Stensman; Christer Larsson
Journal:  BMC Cancer       Date:  2008-12-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.